Marshall Wace’s Myriad Genetics MYGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Buy |
+68,026
| New | +$361K | ﹤0.01% | 2126 |
|
|
2024
Q4 | – | Sell |
-114,306
| Closed | -$3.13M | – | 2659 |
|
|
2024
Q3 | $3.13M | Buy |
+114,306
| New | +$3.13M | ﹤0.01% | 1098 |
|
|
2024
Q2 | – | Sell |
-33,557
| Closed | -$715K | – | 2546 |
|
|
2024
Q1 | $715K | Buy |
+33,557
| New | +$715K | ﹤0.01% | 1565 |
|
|
2023
Q1 | – | Sell |
-147,004
| Closed | -$2.13M | – | 2441 |
|
|
2022
Q4 | $2.13M | Buy |
+147,004
| New | +$2.13M | ﹤0.01% | 1336 |
|
|
2022
Q2 | – | Sell |
-91,025
| Closed | -$2.3M | – | 2998 |
|
|
2022
Q1 | $2.3M | Buy |
+91,025
| New | +$2.3M | ﹤0.01% | 1577 |
|
|
2020
Q4 | – | Sell |
-78,441
| Closed | -$1.02M | – | 1943 |
|
|
2020
Q3 | $1.02M | Sell |
78,441
-149,211
| -66% | -$1.95M | 0.01% | 993 |
|
|
2020
Q2 | $2.58M | Buy |
+227,652
| New | +$2.58M | 0.02% | 675 |
|
|
2019
Q3 | – | Sell |
-155,916
| Closed | -$4.33M | – | 1796 |
|
|
2019
Q2 | $4.33M | Buy |
+155,916
| New | +$4.33M | 0.04% | 515 |
|
|
2019
Q1 | – | Sell |
-336,435
| Closed | -$9.78M | – | 1933 |
|
|
2018
Q4 | $9.78M | Buy |
+336,435
| New | +$9.78M | 0.1% | 244 |
|
|
2017
Q1 | – | Sell |
-10,675
| Closed | -$178K | – | 594 |
|
|
2016
Q4 | $178K | Sell |
10,675
-108,255
| -91% | -$1.81M | ﹤0.01% | 929 |
|
|
2016
Q3 | $2.45M | Sell |
118,930
-202,731
| -63% | -$4.17M | 0.02% | 553 |
|
|
2016
Q2 | $9.84M | Buy |
+321,661
| New | +$9.84M | 0.08% | 242 |
|
|
2015
Q2 | – | Sell |
-458,080
| Closed | -$16.2M | – | 993 |
|
|
2015
Q1 | $16.2M | Buy |
+458,080
| New | +$16.2M | 0.21% | 131 |
|